2m 2m 2m 2m 2m 2m 2m
Lyra Therapeutcs (LYRA)
OTC
$0.35-$0.13 (-26.74%)
Price as of Mar 16, 2026 7:59 PM EDT- $781,125.00Market Cap
- -93.19%1-Year Change
- BiotechnologyIndustry
Lyra Therapeutcs (LYRA)
$0.35-$0.13 (-26.74%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 42
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.48
$0.48
$0.48
1-Year Range
$0.37
$8.09
$0.48
Latest Close$0.48
Change
-$0.02 (-5.26%)
Volume204
Market Cap$781,125.00
Shares Outstanding1.8M
P/E (TTM)-0.02
Diluted EPS (TTM)-$22.95
Enterprise Value-$21.3M
Information as of 07/29/2026
Company Profile
LYRA THERAPEUTICS INC
$781,125.00
Market Cap
-$32.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
LYRA THERAPEUTICS INC
Key Executives
- Vineeta Belanger
- Allison Nance
- Ronan O'Brien
- Elazer R. Edelman FACC
- Carmichael S. Roberts Jr.
Current Ownership Distribution
- Institutions367.4M (65.56%)
- Mutual Funds178.2M (31.79%)
- Insiders14.8M (2.65%)
- Other0 (0.00%)